phosphatidylcholines has been researched along with loxoribine in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (loxoribine) | Trials (loxoribine) | Recent Studies (post-2010) (loxoribine) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 74 | 1 | 24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erridge, C; Kennedy, S; Spickett, CM; Webb, DJ | 1 |
1 other study(ies) available for phosphatidylcholines and loxoribine
| Article | Year |
|---|---|
Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
Topics: Acute-Phase Proteins; Animals; Carrier Proteins; Cell Line; Female; Flagellin; Guanosine; Humans; I-kappa B Kinase; Immunologic Factors; Lipopolysaccharide Receptors; Lipopolysaccharides; Lymphocyte Antigen 96; Macrophages, Peritoneal; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Phosphatidylcholines; Phosphorylation; Poly I-C; Reactive Oxygen Species; RNA; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2008 |